Wednesday, October 21, 2015


Dear readers,

     Today we are discussing one more pharma stock from small cap segments,









BIBCL is a leading biotechnology company based in Uttar Pradesh India. The company is a Govt. of India Undertaking and has its OPV plant in state of Uttar Pradesh, India. The company currently manufactures and produces a range of pharmaceuticals products such as Oral Polio Vaccines (OPV Vaccine), Zinc Tablet & Diarrhea Management Kit etc.

Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science & Technology, Government of India. BIBCOL was established as a Public Sector Unit in 1989, with the aim to achieve self sufficiency for the nation with respect to production and supply of high quality polio vaccine, a dream project of the Former Prime Minister Late Shri. Rajiv Gandhi.

BIBCL'S principal mission is to save the lives of millions of children from avoidable disability, through polio vaccination. Since its inception, it has contributed significantly to the eradication of Poliomyelitis in the country through the National Immunization Program. BIBCL is the pioneer in the field of polio vaccines, capturing 60% of total market share in India. . Based on the performance of the company and its world class WHO-cGMP certified infrastructure, highly skilled manpower and constant support from DBT, Government of India, BIBCOL is one among the top 20 Biotech companies in India, as revealed by recent market surveys.




BIBCL's Products

Product's NameDescription
Diarrhea Managment Kit
Diarrhea Management Kit (Zinc Tablet + ORS) for management of diarrhea among young children.
Oral Polio Vaccine
The live oral polio vaccine (OPV) is a trivalent vaccine containing suspensions of type 1,2 and 3 attenuated poliomyelitis viruses (Sabin strains) prepared in primary moneky kidney cell culture. 
Zinc Dispersable Tablet
The dispersible zinc tablet, BIBZinC-20mg contains 20 mg of elemental zinc as active ingredient and contains sweetener and taste masker (Vanilla flavor) and is scored tablet. The product is in line with the recommendations of WHO. The product is produced with technology transfer from Nutriset (French Company) through Department of Biotechnology, Ministry of Science and Technology, Government of India. The Nutriset product has been tested in Indian fields and clinical trials have evaluated the efficacy of zinc supplementation and safety.
IFA Tablets
Iron Defeciency Anemia (IDA) is most ignored in developing countries and is the major cause of anemia. The Iron Folic Tablets (IFA Tablets) are crucial component for treatment of Iron Defeciency and IDA

             President of India holding 59.25% stake for the company , latest results company posted net loss but government new health program boost company's growth in coming years. Stock trading only  in BSE @ 33.50 LEVEL high risk taker can buy and hold this stock for good return in medium to long term portfolio. This stock may be a disinvestment candidate.

     Company web site HERE

      Before buying take advice from certified person.

  Disclosure :- I am holding this company shares.


  1. hello sir, any views on Black rose industrues i am around 28.. suggest me.

    1. No change my old view, I have recommended this stock @ 22 level, after that stock appreciated 50% (33 level) long term investor hold.

  2. Good share to hold. Good findings from u. Hates up

  3. Worth to buy. Nice findings from you.

  4. Any view on JAUSS POLYMERS

  5. Sir ur view Krebs bio chemicals and godavari drugs